Rare diseases
Investigational molecules
Locations
Back to France1 478 clinical trials in Marseille, France across 7 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on the Safety and Tolerability of Spartalizumab for Patients with Advanced Cancer
FranceComparing drug combinations with panitumumab for patients with RAS and B-RAF wild-type metastatic colorectal cancer
FranceStudy on the Safety and Effects of IPH6501 for Patients with Relapsed or Refractory Non-Hodgkin Lymphoma
FranceStudy on the Effectiveness of Inebilizumab for Patients with IgG4-Related Disease
FranceStudy on the Effectiveness and Safety of Ravulizumab for Children and Adolescents with Neuromyelitis Optica Spectrum Disorder (NMOSD)
FranceStudy on Chemotherapy with Paclitaxel, Cisplatin, and Carboplatin for Patients with Resected Stage I or IIA Non-Squamous Non-Small Cell Lung Cancer
FranceStudy on the Effects of NX210c and Glucose in Adults with Amyotrophic Lateral Sclerosis (ALS)
FranceStudy on Benralizumab and Mepolizumab for Patients with Eosinophilic Granulomatosis with Polyangiitis (EGPA) Receiving Standard Care
FranceStudy of Eptinezumab as Add-on Treatment for Prevention of Migraine in Adults with Both Migraine and Medication Overuse Headache
FranceStudy on Crizanlizumab for Adolescents and Adults with Sickle Cell Disease Experiencing Vaso-Occlusive Crises
FranceStudy on Teclistamab and Drug Combination for Newly Diagnosed Multiple Myeloma Patients
FranceStudy Comparing Nivolumab, Nivolumab with Ipilimumab, or Chemotherapy for Patients with Metastatic Colorectal Cancer with High Microsatellite Instability
FranceThe busiest research cities in the country
What the registry says about research in the country
Studies focusing on innovative treatments for head and neck squamous cell carcinoma, examining novel therapies and combinations with radiotherapy. Research includes investigations into endometrial cancer and bladder cancer treatments.
Particular emphasis on combining immunotherapy with conventional treatments for improved patient outcomes.
Innovative research addressing heart failure prevention and treatment of acute myocardial infarction. Studies include new approaches for managing hypertriglyceridemia and chronic kidney disease.
Focus on developing novel therapeutic approaches and improving patient outcomes in cardiovascular health.
Clinical investigations into multiple sclerosis treatment strategies and management of essential tremor. Research includes innovative approaches for Dravet Syndrome and neurological disorders.
Emphasis on developing targeted therapies for various neurological conditions affecting both adults and children.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
